June 16, 2021 | BALTIMORE – Complete Omics’ Clinical Proteomics team announced a collaboration with Dr. Yonghong Wan’s lab at McMaster University at Hamilton Ontario Canada.
Dr. Wan is a professor in Pathology and Molecular Medicine. And his lab in McMaster University has been focusoing on on the development of immunotherapies for the treatment of cancer, with an emphasis on the combination of adoptive T cell therapy (ACT) and oncolytic virus-based vaccines (OV).
Through collaborating with Complete Omics, Dr. Wan’s lab is trying to identify fundamental regulation mechanisms of neoantigen presentation. The project is directly lead by Scott Walsh PhD, a junior faculty in Dr. Wan’s lab.